Product Information

OXCARBAZEPINE 300 MG TABLET is a generic product labeled by American Health Packaging, priced at $0.1741 per EA under NDC 60687072201. Its NADAC has been published 196 times since Feb 22, 2023.

FDA first approved this application on Jan 11, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OXCARBAZEPINE 300 MG TABLET

Oxcarbazepine
$0.1741per EA

Strength

300 mg/1

NDC

60687072201

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

OXCARBAZEPINE

Approval Type

Generic (ANDA)

FDA Application

ANDA215939

FDA Approved

1/11/2022

TE Code

AB

On Market Since

1/24/2023

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for OXCARBAZEPINE 300 MG TABLET has been published 196 times since Feb 22, 2023, and over the history we have for it it has declined 17.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1741 per EA
All-time high$0.2109 (Apr 10, 2024)
All-time low$0.1454 (Nov 20, 2024)
52-week high$0.1745
52-week low$0.1635
Median price$0.1778
Average price$0.1826
Largest weekly change+25.1% (Aug 21, 2024)
Weeks tracked196
Tracking sinceFeb 22, 2023

Price History

1W

+1.6%

1M

+4.4%

3M

+6.3%

6M

+4.5%

1Y

+1.3%

3Y

-14.3%

5Y

N/A

All

-17.0%

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of OXCARBAZEPINE 300 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for OXCARBAZEPINE 300 MG TABLET, manufactured by American Health Packaging, is $0.1741 per EA (NDC 60687072201), effective Nov 18, 2026.

How has the price of OXCARBAZEPINE 300 MG TABLET changed over time?

Over the history we have for it, the NADAC for OXCARBAZEPINE 300 MG TABLET has declined 17.0%. It has been tracked across 196 weekly CMS publications since Feb 22, 2023.

What are the highest and lowest recorded NADAC prices for OXCARBAZEPINE 300 MG TABLET?

Since Feb 22, 2023, the NADAC for OXCARBAZEPINE 300 MG TABLET has ranged from a low of $0.1454 (Nov 20, 2024) to a high of $0.2109 (Apr 10, 2024), with a median of $0.1778 per EA.

Are there cheaper alternatives to OXCARBAZEPINE 300 MG TABLET?

Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OXCARBAZEPINE 300 MG TABLET, is $0.1691 per EA — about 3% below OXCARBAZEPINE 300 MG TABLET.

Who manufactures OXCARBAZEPINE 300 MG TABLET?

OXCARBAZEPINE 300 MG TABLET (NDC 60687072201) is labeled by American Health Packaging, and CMS classifies it as a generic product.